Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
THANK YOU FOR SUBSCRIBING
This article is part of Med Tech Outlook's Innovation Insights series featuring expert contributions nominated by our subscribers and reviewed by our editorial team.
Daniel Hofmann, Chief Executive Officer , I-MED Pharma
Editor’s Note: Medtech executives must remain responsive when technological change, shifting care models and new operating realities accelerate simultaneously. Hofmann’s perspective highlights the value of adaptability and timely decision-making as healthcare companies evaluate remote diagnostics, automation and emerging technologies while reshaping their organizations for a faster-moving business environment.
The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info
